Impact Factor
3.28
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.81
347 total citations
h5-index
19
h5 depth signal
Cited share
79.0%
98 of 124
Total citations
347
Citation footprint
Metric signal
2.78
External metric anchor
Self-citation
10.1%
35 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Italy
132
United States
110
United Kingdom
43
Spain
37
Japan
32
Citing Fields of Research
Psychiatry
432
Neurosciences
45
Substance Abuse
36
Chronobiology
27
Neurodevelopmental Disorders
24
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,478
Articles tracked across the journal lifetime
Indexed publication set
124
98 cited publications
Last 12 months
39
3.5 publications/month
Open access share
20.5%
8 OA publications in the last year
Leading citing country
Italy
132 citing publications
Leading citing field
Psychiatry
432 citing publications
Latest tracked publication
30 September 2026
10 recent records available
Coverage & Indexing History
v1n1, 1986-
v1n1, 1986-
Active Coverage
Research Focus & Classification
Indexed Subjects
Psychiatry
Broad Categories
Psychopharmacology
Psychiatry
MeSH Descriptors
Psychopharmacology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/yic.0000000000000639
Open DOI
Attributing benefit and harm in clinical practice: medication burden, causality, and pharmacovigilance
Was not provided for this article.
02
DOI 10.1097/yic.0000000000000637
Open DOI
Lithium-associated peripheral transcriptional signatures correlate with brain white matter microstructure in bipolar disorder
Lithium is the mainstay treatment for bipolar disorder, improving brain white matter microstructure and regulating genes involved in immune response and cell signaling. In 116 patients affected by a major depressive episode in the course...
03
DOI 10.1097/yic.0000000000000634
Open DOI
Use of risperidone in-situ microparticles in real world: patterns of prescription and dose selection in patients with psychotic disorders
Long-acting injectable (LAI) antipsychotics are important for improving adherence and preventing relapse. Risperidone in-situ microparticles (ISM), a once monthly LAI using ISM technology, rapidly achieves therapeutic plasma levels witho...
04
DOI 10.1097/yic.0000000000000638
Open DOI
Efficacy and safety of intramuscular and intravenous midazolam for acute agitation in emergency settings: a systematic review
Acute agitation often requires parenteral sedation in emergency care. Midazolam is widely used for its rapid onset, short duration of action, and availability for intramuscular and intravenous administration, but its efficacy and safety ...
05
DOI 10.1097/yic.0000000000000633
Open DOI
Resistant depression, biomarkers, and comorbidity in clinical practice
Was not provided for this article.
06
DOI 10.1097/yic.0000000000000629
Open DOI
Not all antipsychotic polypharmacy is the same
Was not provided for this article.
07
DOI 10.1097/yic.0000000000000636
Open DOI
Lithium and GLP-1-based therapies in bipolar disorder: an emerging pharmacovigilance signal and monitoring considerations
Lithium remains a cornerstone of bipolar disorder treatment, yet it has a narrow-therapeutic index and depends on renal and volume status. Glucagon-like peptide-1 (GLP-1) receptor agonists and dual glucose-dependent insulinotropic polype...
08
DOI 10.1097/yic.0000000000000635
Open DOI
Effectiveness and safety of long-acting aripiprazole 960 mg: preliminary findings from a prospective real-world observational study
Poor treatment adherence is a major challenge in the management of severe mental disorders, as it is associated with an increased risk of relapse, rehospitalization, symptom worsening, treatment resistance, and all-cause mortality. In 20...
09
DOI 10.1097/yic.0000000000000632
Open DOI
Critical reassessment of manic and psychotic episodes related to levetiracetam: a systematic review of published case reports
Levetiracetam (LEV) is a widely used antiepileptic but associated with psychiatric side effects. While mild reactions are common, manic and psychotic episodes are less frequent, though clinically significant. This review critically asses...
10
DOI 10.1097/yic.0000000000000631
Open DOI
Antipsychotics in clinical practice: agitation, polypharmacy, and treatment resistance
Bibliographical & Catalog Notes
Title from cover.
Some vols. have supplements.
Also issued online.
Vol. 7, no. 1 (1992)19920824 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper